483
Axsome Therapeutics, Inc.Axsome Therapeutics, Inc. – FDA 483, Feb 6, 2026
Record Details
An FDA inspection of Axsome Therapeutics, Inc. in New York, NY, revealed significant deficiencies in their oversight of clinical trials. The firm failed to notify the FDA of an investigator's termination for cause and did not ensure studies were conducted according to protocol and monitoring plans. These issues indicate a lack of proper control over clinical trial conduct and documentation.
View Company Profile
ID · cac8d33c-b337-4a4b-b724-23a82c6eb011
Other documents for Axsome Therapeutics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.